5-氨基-3-(2-吡啶基))-1H-吡唑 | 92352-29-9
中文名称:
5-氨基-3-(2-吡啶基))-1H-吡唑
英文名称:
3-(pyridin-2-yl)-1H-pyrazol-5-amine
CAS No.:
92352-29-9
分子式:
C8 H8 N4
分子量:
160.17592048645
名称和标识符
MDL
MFCD06738755
InChIKey
RJFHMLHZCNZQMA-UHFFFAOYSA-N
Inchi
1S/C8H8N4/c9-8-5-7(11-12-8)6-3-1-2-4-10-6/h1-5H,(H3,9,11,12)
SMILES
N1C(C2NN=C(N)C=2)=CC=CC=1
别名信息
- 中文别名 -
5-氨基-3-(2-吡啶基))-1H-吡唑
5-吡啶-2-基-2H-吡唑-3-胺
- 英文别名 -
5-Pyridin-2-yl-2H-pyrazol-3-ylamine
1H-Pyrazol-3-amine,5-(2-pyridinyl)-
5-(PYRIDIN-2-YL)-1H-PYRAZOL-3-AMINE
5-Amino-3-(pyrid-2-yl)-1H-pyrazole
5-pyridin-2-yl-1H-pyrazol-3-amine
3-pyridin-2-yl-1H-pyrazol-5-amine(SALTDATA: 1.9HCl)
3-(pyridin-2-yl)-1H-pyrazol-5-amine
1H-Pyrazol-3-amine, 5-(2-pyridinyl)-
RJFHMLHZCNZQMA-UHFFFAOYSA-N
HMS1699O06
3-(2-pyridyl)pyrazole-5-ylamine
SBB010423
3-pyridin-2-yl-1H-pyrazol-5-amine
5-(2-Pyridyl)-1H-pyrazole-3-amine
3-(2-Pyridyl)-1H-pyrazole-5-amine
AB27820
5
5-(2-Pyridinyl)-1H-pyrazol-3-amine (ACI)
Pyridine, 2-[5(or 3)-aminopyrazol-3(or 5)-yl]- (7CI)
3-Amino-5-(2-pyridyl)-1H-pyrazole
5-(Pyridin-2-yl)-2H-pyrazol-3-amine
5-Amino-3-(pyridin-2-yl)-1H-pyrazole
物化性质
实验特性
LogP
1.63510
PSA
67.59000
计算特性
精确分子量
160.07500
氢键供体数量
2
氢键受体数量
3
可旋转化学键数量
1
重原子数量
12
复杂度
150
拓扑分子极性表面积
67.6
海关数据
海关编码
2933990090
海关数据
中国海关编码:
2933990090
概述:
2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素:
品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
合成路线
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
rt → 78 °C; 20 h, 78 °C
参考文献:
Multisubstituted aromatic compounds as inhibitors of thrombin and their preparation
,
United States ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
18 h, reflux
1.2
Reagents:
Acetic acid
Solvents:
Acetic acid
;
overnight, 80 °C
1.3
Reagents:
Hydrochloric acid
Solvents:
Water
;
overnight, 60 °C
参考文献:
Azoles as nicotinic acetylcholine receptor modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
rt → 78 °C; 20 h, 78 °C
参考文献:
Multisubstituted pyrazole and triazole compounds as serine protease inhibitors and their preparation, pharmaceutical compositions and use in the treatment of kallikrein related diseases
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
18 h, reflux
1.2
Reagents:
Acetic acid
Solvents:
Acetic acid
;
overnight, 80 °C
1.3
Reagents:
Hydrochloric acid
Solvents:
Water
;
overnight, 60 °C
参考文献:
Pyrazole derivatives as alpha7 nicotinic acetylcholine receptor inhibitors and their preparation
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
overnight, rt → reflux
参考文献:
Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents and their preparation, pharmaceutical compositions and use in the treatment of coronavirus infection
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
20 h, reflux
参考文献:
Synthesis of a new series of ditopic proligands for metal salts: differing regiochemistry of electrophilic attack at 3{5}-amino-5{3}-(pyrid-2-yl)-1H-pyrazole
Pask, Christopher M.;
Camm, Kenneth D.;
Kilner, Colin A.;
Halcrow, Malcolm A. ,
Tetrahedron Letters ,
2006 ,
47(15) ,
2531-2534
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
24 h, reflux
参考文献:
Bifunctional Copper-Based Photocatalyst for Reductive Pinacol-Type Couplings
Caron, Antoine;
Morin, Emilie;
Collins, Shawn K. ,
ACS Catalysis ,
2019 ,
9(10) ,
9458-9464
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
18 h, reflux
1.2
Reagents:
Acetic acid
Solvents:
Water
;
overnight, 80 °C
1.3
Reagents:
Hydrochloric acid
Solvents:
Water
;
overnight, 60 °C
参考文献:
Processes for preparation of acylaminoarylpyrazole hydrochloride salts
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
参考文献:
Multisubstituted aromatic compounds as inhibitors of thrombin and their preparation
,
United States ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
,
Water
;
18 h, reflux
参考文献:
Preparation of 5- or 7-azaindazoles as β-lactamase inhibitors
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
overnight, rt → reflux
参考文献:
Preparation of substituted pyrazolo-pyrimidines as PIKfyve inhibitors useful for treatment of neurological diseases
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine
Catalysts:
Acetic acid
Solvents:
Ethanol
;
5 h, rt → 80 °C
参考文献:
Synthesis of fused tricyclic heterocyclic PIKfyve kinase inhibitors for the treatment of neurological diseases
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Acetic acid
,
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
rt; 20 h, reflux
参考文献:
Preparation of fused heterocyclic compounds as novel anti-platelet agents
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine
Solvents:
Ethanol
;
24 h, reflux
参考文献:
N-Pyrazolo[3,4-b]pyridinyl benzamide derivatives as Raf inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Solvents:
Ethanol
;
rt → reflux; 20 h, reflux
参考文献:
Multisubstituted aromatic compounds as inhibitors of thrombin and their preparation and use in the treatment of thrombotic disorders
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
1.1
Reagents:
Hydrazine hydrate (1:1)
Catalysts:
Acetic acid
Solvents:
Ethanol
;
5 h, rt → 80 °C
参考文献:
Pyridofuropyrimidines and methods for preparation and treatment of viral infection caused by SARS-CoV-2
,
World Intellectual Property Organization ,
,
,
合成路线:1 步
参考文献:
Preparation of fused heterocyclic compounds as novel anti-platelet agents
,
Japan ,
,
,
合成路线:1 步
参考文献:
Preparation of (arylsulfanylmethyl)pyrazolo[1,5-a]pyrimidinol derivatives as CXCR2 antagonists
,
World Intellectual Property Organization ,
,
,